Skip to main content

Table 1 Results of IL-1α or IL-1β mRNA expression in several tumor cell lines evaluated by quantitative RT-PCR.

From: Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Human tumor cell lines IL-1α* IL-1β*
SMEL (melanoma) 3,267 0
WIDR (colon cancer) 1 122,932
H2030 (NSCLC) 0 29,084
PMEL (melanoma) 35 67
SL-2 (squamous cell cancer) 140 0
  1. * Gene expression is expressed as copy number per 105 copies of β-actin; copy number > 1,000/105 copies β-actin is in boldface.